Immunocore Holdings plc (NASDAQ:IMCR) Accelerates Toward Near-Term Catalyst-Driven Upside
Robust liquidity and accelerating clinical progress position the company for active near-term activity; technical momentum favors additional upside while a valuation gap leaves room for re-rating.






